Research graph
References from Interferon signature in anti-neutrophil cytoplasmic antibody–negative patients. Local targets link to admitted publications; unresolved targets remain external evidence.
the Maine-Anjou Registry Research Group. A stronger type I interferon signature distinguishes ANCA-associated vasculitis phenotypes and predicts kidney prognosis
10.1016/j.kint.2025.07.034 · 2026 · External reference
ANCA-negative pauci-immune glomerulonephritis: a review
10.1159/000541792 · 2024 · External reference
ANCA-negative pauci-immune necrotizing glomerulonephritis: a case series and a new clinical classification
10.1053/j.ajkd.2021.03.027 · 2022 · External reference
Clinical presentation and outcomes of antineutrophil cytoplasmic autoantibody–negative pauci-immune glomerulonephritis
10.1016/j.ekir.2025.02.032 · 2025 · External reference
Clinical presentation and outcomes of antineutrophil cytoplasmic autoantibody–negative pauci-immune glomerulonephritis
10.1016/j.ekir.2025.02.032 · ExternalCitation · doi-reference
the Maine-Anjou Registry Research Group. A stronger type I interferon signature distinguishes ANCA-associated vasculitis phenotypes and predicts kidney prognosis
10.1016/j.kint.2025.07.034 · ExternalCitation · doi-reference
ANCA-negative pauci-immune necrotizing glomerulonephritis: a case series and a new clinical classification
10.1053/j.ajkd.2021.03.027 · ExternalCitation · doi-reference
ANCA-negative pauci-immune glomerulonephritis: a review
10.1159/000541792 · ExternalCitation · doi-reference
